HR 2774, the Accelerating Individuals into the Workforce Act, creates federal grants for states to run demonstration projects providing wage subsidies to help Temporary Assistance for Needy Families (TANF) recipients and low-income adults (unemployed or earning under 200% of the federal poverty line) enter and keep jobs. States must design subsidy programs covering up to 50% of wages for up to 12 months per participant, while ensuring no job displacement and coordinating with other workforce programs. The bill requires states to report monthly on participants, retention rates in unsubsidized jobs after 2-4 quarters, and median earnings, and mandates a rigorous federal evaluation using randomized trials or strong research methods. Funds are reserved at $100 million for fiscal year 2023, with implementation starting October 1, 2023.
HR 2707, the MADE in America Act, creates a 25-30% federal tax credit for manufacturers producing specific health products (including drugs, medical devices, personal protective equipment, and diagnostic tools) in designated "distressed zones." These zones are census tracts with over 30% poverty rates that are also designated as qualified opportunity zones. The credit applies to wages paid to employees working in these zones and qualified production costs (like equipment and materials), increasing to 30% if most employees reside locally. It directly affects pharmaceutical and medical device manufacturers operating in eligible low-income areas, aiming to incentivize domestic production of critical health products.
HR 2667, the "Fighting Trade Cheats Act of 2023," increases penalties for importers who commit customs fraud or gross negligence. It triples civil penalties for fraudulent violations (to three times the domestic value) and raises gross negligence penalties to ten times, while adding five-year import bans for fraud and two-year bans for gross negligence. The bill also allows U.S. businesses, unions, or trade groups harmed by such violations to sue violators in federal court for triple damages, attorney fees, and injunctions against further imports. Additionally, it excludes violators and their affiliated companies from the Importer of Record program, with special rules to block shell companies evading customs laws. This directly affects importers who violate customs laws and U.S. businesses competing with those imports.
This bill would require Medicare to cover FDA-approved blood tests that screen for multiple cancers simultaneously (like breast, lung, or colorectal cancer) for beneficiaries. It directly affects Medicare recipients aged 65+ who could access these new screenings once per year, without prior authorization. The key provision adds "multi-cancer early detection screening tests" to Medicare's covered services under Part B, defining them as blood tests analyzing cell-free DNA, while maintaining existing coverage for standard screenings like mammograms. The bill does not change current coverage for individual cancer screenings but ensures Medicare keeps pace with new medical technology.
HR 1755 allows the U.S. President to grant Uzbekistan permanent normal trade relations (NTR) status, removing special tariffs on Uzbek exports entering the U.S. market. It terminates the requirement for annual U.S. reviews of Uzbekistan's trade status under a 1974 law. The change takes effect only after Uzbekistan joins the World Trade Organization (WTO). This directly affects Uzbekistan's exporters by enabling their goods to enter the U.S. under standard tariff rates.
This bill expands Medicare Part B coverage to include specific pharmacist services, directly affecting Medicare beneficiaries and pharmacists who provide these services. It adds new coverage for pharmacist evaluations and treatments related to certain illnesses (like COVID-19, flu, or strep throat) and public health emergencies, requiring payment at 80% of the lesser of actual charge or 85% of physician payment rates (100% during emergencies). The bill also prohibits balance billing for these services, ensuring beneficiaries pay only the standard Medicare copayment. These changes aim to improve access to pharmacist care during health crises while aligning payment with existing physician service frameworks.
The Emergency Care Improvement Act would permanently allow freestanding emergency centers (FECs) to receive Medicare and Medicaid reimbursement for emergency services. FECs are independently licensed facilities operating 24/7 with on-site physicians, providing emergency care equivalent to hospital-based emergency rooms. The bill sets payment rates for FECs equal to hospital outpatient department rates for higher-level emergency services, based on existing Medicare payment structures. This change would apply to over 110 FECs, mostly in Texas, which previously operated under a temporary pandemic waiver and demonstrated 21.8% cost savings to Medicare for similar care.
HR 1666 extends deadlines for ambulance service reimbursement rules under Medicare. It amends Section 1834(l) of the Social Security Act by changing dates from 2025 to 2028 in two specific provisions: paragraph (12)(A) and paragraph (13)(A). This delay gives ambulance providers additional time to adjust to existing Medicare payment rules. The bill directly affects Medicare-certified ambulance services and the patients relying on ground ambulance care covered by Medicare.
HR 1610 would modernize Medicare coverage for chiropractic care by removing the current restriction that limited beneficiaries to one chiropractic service per visit. It expands coverage to include all services provided by licensed chiropractors within their state-authorized scope, aligning Medicare with VA, military, and private insurance practices. The bill requires chiropractors to complete a Secretary-approved educational webinar to cover non-spinal services, while still allowing payment for spinal manipulation treatments without this requirement. This directly affects Medicare beneficiaries seeking chiropractic care and chiropractors seeking Medicare reimbursement for their services.
This bill makes permanent Medicare coverage for cardiac and pulmonary rehabilitation services delivered via telehealth in patients' homes, which were temporarily allowed during the pandemic. It removes geographic restrictions that previously required in-person visits or limited services to specific locations like clinics. The change directly affects Medicare beneficiaries needing heart or lung rehabilitation and healthcare providers offering these programs. It ensures home-based telehealth visits for cardiac, intensive cardiac, and pulmonary rehabilitation receive the same coverage as in-clinic services under Medicare.
HR 1276, the "Protect Minors from Medical Malpractice Act of 2023," creates a legal right for minors who undergo gender-transition procedures before age 18 to sue medical practitioners for harms (physical, psychological, or emotional) related to those procedures. It allows such individuals to file civil lawsuits up to 30 years after turning 18, seeking damages, injunctions, or attorney fees. The bill defines "gender-transition procedure" broadly to include puberty blockers, cross-sex hormones, or surgeries, but excludes treatments for intersex conditions, medical emergencies, or injuries caused by prior procedures. This law directly affects minors receiving such care, medical practitioners performing these procedures, and states that might require them. The bill does not prohibit gender-transition care but establishes a liability framework for practitioners.
HR 751, the FAIR Act, requires hospitals running medical residency programs to report annual data on applicants and acceptances from both osteopathic (DO) and allopathic (MD) medical schools starting in 2024. Specifically, hospitals must submit the number of applicants and accepted candidates from each medical school type, confirm they accept both DO and MD applicants, and state that COMLEX and USMLE exam scores are equally accepted. The Health Secretary must then publish this data online for public transparency. The bill directly affects hospitals operating residency programs and aims to make their admissions processes more visible, without mandating specific acceptance rates or changing admission criteria.
